ArticleMedical oncology (Northwood, London, England)2023

Efficacy and safety of EGFR inhibitor gefitinib in recurrent or metastatic cervical cancer: a preliminary report.

Abhishek Krishna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.